SCHEMBL12966543

SCHEMBL12966543

CC(Oc1c(Br)cc(C(=O)c2ccc(N=NN(C)C)cc2)cc1Br)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ THRA P10827 2/20 0.33
▸ THRB P10828 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GABRA1 P14867 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12966898 0.87 MAPT (0.53) NPC1MAPTRAB9ALMNAHPGD
SCHEMBL47287 0.83 MAPT (0.48) NPC1MAPTRAB9ALMNACYP1A2
SCHEMBL12966626 0.83 MAPT (0.48) NPC1MAPTRAB9ALMNACYP1A2
SCHEMBL12966623 0.79 NPC1 (0.42) NPC1MAPTRAB9ALMNACYP1A2
SCHEMBL12966622 0.78 NPC1 (0.44) NPC1MAPTRAB9ALMNACYP1A2
SCHEMBL12966544 0.76 KMT2A (0.46) NPC1MAPTRAB9ACYP1A2CYP2C19
SCHEMBL14699615 0.72 RAB9A (0.55) NPC1MAPTRAB9ALMNAHPGD
SCHEMBL14699621 0.72 RAB9A (0.55) NPC1MAPTRAB9ALMNAHPGD
SCHEMBL12966662 0.70 MAPT (0.51) NPC1MAPTRAB9AALDH1A1
SCHEMBL12966537 0.69 CYP1A2 (0.46) NPC1MAPTRAB9ACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130850-A1 TISSUE TARGETING BY MEANS OF ONCOCIDAL BRIDGED DIPHENYL DERIVATIVES FOR THE SELECTIVE TREATMENT OF SEXUAL ORGAN TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-04 — — WO disclosed
Send feedback